Stock Events

Stock Events

Abbvie 

C$40.84
33574
+C$1.20+3.03% 20:57 Today

Statistics

Day High
40.84
Day Low
39.4
52W High
41.1
52W Low
26.89
Volume
93,100
Avg. Volume
-
Mkt Cap
72.17B
P/E Ratio
68.75
Dividend Yield
2.34%
Dividend
0.96

Upcoming

Dividends

2.34%Dividend Yield
Nov 2026
C$0.24
Aug 2026
C$0.24
May 2026
C$0.24
Feb 2026
C$0.24
Nov 2025
C$0.23
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
13%
1Y Growth
1.57%

Earnings

Feb 3Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
2.47
3.47
4.46
5.45
Expected EPS
5.448356286659999
Actual EPS
N/A

Financials

6.92%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
84.95BRevenue
5.88BNet Income

Analyst Ratings

$334.47Average Price Target
The highest estimate is ⁦377.60⁩.
From 19 ratings within the last 6 months. This is not an investment recommendation.
Buy
84%
Hold
16%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABBV.TO. It's not an investment recommendation.
Realty Income
10001
O
Microsoft
8506
MSFT
Apple
8407
AAPL
Coca-Cola
7316
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson competes with AbbVie in the pharmaceutical sector, particularly in immunology and oncology.
Pfizer
PFE
Mkt Cap173.95B
Pfizer competes across several therapeutic areas including immunology and oncology, similar to AbbVie's portfolio.
Merck
MRK
Mkt Cap368.89B
Merck is a key competitor in the pharmaceutical industry, especially in the oncology market where both companies have significant investments.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline competes with AbbVie in the pharmaceutical and healthcare sector, with overlapping interests in immunology.
Novartis
NVS
Mkt Cap303.67B
Novartis competes with AbbVie in multiple areas including immunology and neuroscience.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb competes in the biopharmaceutical sector, particularly in oncology and cardiovascular diseases, areas where AbbVie is also active.
AMGEN
AMGN
Mkt Cap251.94B
Amgen competes with AbbVie in the biotech sector, particularly in treatments for inflammatory diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes with AbbVie in the oncology and immunology sectors, with a strong focus on biopharmaceuticals.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes with AbbVie in areas such as immunology, with both companies developing treatments for various autoimmune diseases.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca competes with AbbVie, particularly in the oncology sector, where both companies are seeking to expand their portfolios.

About

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Show More
CEO
Robert A. Michael
Employees
57000
Country
United States
ISIN
CA00288K1084
WKN
000A3DXS3

Listings

XNYS
US
ABBV
F
DE
4AB.F
STU
DE
4AB.STU
BK
TH
ABBV19.BK

0 Comments

Share your thoughts

FAQs

What is Abbvie stock price today?▼
The current price of ABBV.TO is C$40.84 CAD — it has increased by +3.03% in the past 24 hours. Watch Abbvie stock price performance more closely on the chart.
What is Abbvie stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Toronto Exchange exchange Abbvie stocks are traded under the ticker ABBV.TO.
What is Abbvie market cap?▼
Today Abbvie has the market capitalization of 72.17B
When is the next Abbvie earnings date?▼
Abbvie is going to release the next earnings report on February 3, 2027.
What were Abbvie earnings last quarter?▼
ABBV.TO earnings for the last quarter are 5.34 CAD per share, whereas the estimation was 5.21 CAD resulting in a +2.51% surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is Abbvie revenue for the last year?▼
Abbvie revenue for the last year amounts to 84.95B CAD.
What is Abbvie net income for the last year?▼
ABBV.TO net income for the last year is 5.88B CAD.
Does Abbvie pay dividends?▼
Yes, ABBV.TO dividends are paid quarterly. The last dividend per share was 0.24 . As of today, Dividend Yield (FWD)% is 2.34%.
How many employees does Abbvie have?▼
As of November 4, 2026, the company has 57,000 employees.
In which sector is Abbvie located?▼
Abbvie operates in the Health & Wellness sector.
When did Abbvie complete a stock split?▼
Abbvie has not had any recent stock splits.
Where is Abbvie headquartered?▼
Abbvie is headquartered in NORTH CHICAGO, United States.